Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus

• DOI: 10.1007/s00125-003-1321-3
• Publication Date: 2004-01-23T22:40:39Z
• Authors: Y. M. Cho; M. D. Ritchie; J. H. Moore; J. Y. Park; K.-U. Lee; H. D. Shin; H. K. Lee; K. S. Park
• Keywords: Male; 0301 basic medicine; 0303 health sciences; Polymorphism, Genetic; Models, Genetic; Chromosome Mapping; Membrane Transport Proteins; Middle Aged; Ion Channels; 3. Good health; Mitochondrial Proteins; PPAR gamma; 03 medical and health sciences; Amino Acid Substitution; Diabetes Mellitus, Type 2; Humans; Female; Uncoupling Protein 2; Aged

Type 2 diabetes mellitus is a complex genetic disease, which results from interactions between multiple genes and environmental factors without any single factor having strong independent effects. This study was done to identify gene to gene interactions which could be associated with the risk of Type 2 diabetes.We genotyped 23 different loci in the 15 candidate genes of Type 2 diabetes in 504 unrelated Type 2 diabetic patients and 133 non-diabetic control subjects. We analysed gene to gene interactions among 23 polymorphic loci using the multifactor-dimensionality reduction (MDR) method, which has been shown to be effective for detecting and characterising gene to gene interactions in case-control studies with relatively small samples.The MDR analysis showed a significant gene to gene interaction between the Ala55Val polymorphism in the uncoupling protein 2 gene ( UCP2) and the 161C>T polymorphism in the exon 6 of peroxisome proliferator-activated receptor gamma ( PPARgamma) gene. This interaction showed the maximum consistency and minimum prediction error among all gene to gene interaction models evaluated. Moreover, the combination of the UCP2 55 Ala/Val heterozygote and the PPARgamma 161 C/C homozygote was associated with a reduced risk of Type 2 diabetes (odds ratio: 0.51, 95% CI: 0.34 to 0.77, p=0.0016).Using the MDR method, we showed a two-locus interaction between the UCP2 and PPARgamma genes among 23 loci in the candidate genes of Type 2 diabetes. The determination of such genotype combinations contributing to Type 2 diabetes mellitus could provide a new tool for identifying high-risk individuals.